Ara
Toplam kayıt 1, listelenen: 1-1
Rational Drug Redesign to Overcome Drug Resistance in Cancer Therapy: Imatinib Moving Target
(Amer Assoc Cancer Research, 2007)
Protein kinases are central targets for drug-based cancer treatment. To avoid functional impairment, the cell develops mechanisms of drug resistance, primarily based on adaptive mutations. Redesigning a drug to target a ...